Relmada Therapeutics Announces Levocap ER Development Progress

By WebmasterMarch 4, 2013November 1st, 2024No Comments

Relmada Therapeutics Announces Levocap ER Development Progress
Read more here

Previous PostNovira Therapeutics Completes $25 Million Series A Financing
Next PostCeptaris Resubmits New Drug Application (NDA) to FDA for Proprietary Gel Formulation of Mechlorethamine Hydrochloride